Kerendia 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FXHJL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,846
Award facts
- Contract value 100% obligated
- $7,845.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a ceiling value of $7,845.94. This firm fixed-price delivery order, with an ultimate completion date of November 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award utilized no set-aside designation and was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant $999,999,999.00 IDC (designated SPE2DX) running through December 2026 that serves as the comprehensive vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order supports the federal medical procurement needs of the Defense Health Agency and other government healthcare systems by providing Kerendia, a prescription medication used primarily for chronic kidney disease treatment. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, ranging from specialty medications and brand-name drugs to generic pharmaceuticals and medical devices. The company's consistent performance in delivering federal medical supplies through competitive awards reflects its established role as a critical vendor within the military and veteran healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB26FXHJL?
SPE2DB26FXHJL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FXHJL worth?
The government has obligated $7,846 on SPE2DB26FXHJL.
Is contract SPE2DB26FXHJL an order under another contract?
Yes. SPE2DB26FXHJL is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB26FXHJL competed?
The extent of competition for SPE2DB26FXHJL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award